Skip to main content
Journal ArticleOPEN ACCESS

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

  • Katinger D
  • Wagner A
  • Luque I
  • et al.
Retrovirology (2012) 9(S2)
DOI: 10.1186/1742-4690-9-s2-p354
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Katinger, D., Wagner, A., Luque, I., Crespillo, S., Conejero-Lara, F., Roger, M., … El Habib, R. (2012). Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans. Retrovirology, 9(S2). https://doi.org/10.1186/1742-4690-9-s2-p354

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free